Eidelman Virant Capital Johnson & Johnson Transaction History

Eidelman Virant Capital

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 19, 2021	SELL	$159.48 - $171.07 $535,374 - $574,281	-3,357 Closed	0 $0
Q1 2021 Apr 20, 2021	SELL	$153.07 - $170.48 $22,960 - $25,572	-150 Reduced 4.28%	3,357 $548,000
Q4 2020 Jan 26, 2021	SELL	$137.11 - $157.38 $138,481 - $158,953	-1,010 Reduced 22.36%	3,507 $552,000
Q3 2020 Nov 10, 2020	BUY	$140.38 - $153.83 $145,995 - $159,983	1,040 Added 29.91%	4,517 $671,000
Q2 2020 Jul 10, 2020	BUY	$128.81 - $155.51 $12,881 - $15,551	100 Added 2.96%	3,477 $489,000
Q1 2020 May 06, 2020	SELL	$111.14 - $153.99 $666 - $923	-6 Reduced 0.18%	3,377 $443,000
Q4 2019 Jan 15, 2020	SELL	$127.5 - $146.44 $19,125 - $21,966	-150 Reduced 4.25%	3,383 $493,000
Q3 2019 Oct 29, 2019	SELL	$126.95 - $142.14 $168,208 - $188,335	-1,325 Reduced 27.27%	3,533 $457,000
Q2 2019 Jul 22, 2019	BUY	$131.15 - $144.24 $637,126 - $700,717	4,858 New	4,858 $0
Q4 2018 Jan 18, 2019	SELL	$122.84 - $147.84 $1.05 Million - $1.27 Million	-8,558 Closed	0 $0
Q1 2018 Apr 19, 2018	SELL	$125.1 - $148.14 $81,815 - $96,883	-654 Reduced 7.1%	8,558 $1.1 Million
Q4 2017 Feb 05, 2018	SELL	$131.22 - $143.62 $41,465 - $45,383	-316 Reduced 3.32%	9,212 $0
Q3 2017 Oct 20, 2017	BUY	$129.47 - $135.38 $1.23 Million - $1.29 Million	9,528	9,528 $1.24 Million

4,258

1.68B

16.1M

13.8M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $397B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Eidelman Virant Capital, based on Form 13F filings with the SEC.

Stay updated on Eidelman Virant Capital with notifications on news.